CIK: 0001634557
Total reported value
—
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | PRTA | Prothena Corporation plc | Stock-Other | 29.14% | — | +1.58% | |
| 2 | ALKS | Alkermes plc | Stock-Healthcare | 27.99% | — | +3.41% | |
| 3 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 20.21% | -71.30% | EXIT | |
| 4 | BIIB | Biogen INC | Stock-Healthcare | 7.96% | — | +2.91% | |
| 5 | GILD | Gilead Sciences INC | Stock-Healthcare | 7.63% | — | -5.18% | |
| 6 | ✓ | Bioverativ Inc | Stock-Other | 7.08% | — | -0.61% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALKS | Alkermes plc | +10.9% | +3.41% | Add |
| 2 | TBPH | Theravance Biopharma, Inc. | +3.4% | +0.38% | Add |
| 3 | BIIB | Biogen INC | +2.8% | +2.91% | Add |
| 4 | ✓ | Bioverativ Inc | +1.9% | -0.61% | Trim |
| 5 | GILD | Gilead Sciences INC | +1.4% | -5.18% | Trim |
| 6 | PRTA | Prothena Corporation plc | -4.6% | +1.58% | Add |
| 7 | ABBV | Abbvie INC | — | EXIT | Sold out |